HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36 | +5.9% | 401 | -0.2% | 0.03% | +3.8% |
Q2 2023 | $34 | +3.0% | 402 | -0.5% | 0.03% | -10.3% |
Q1 2023 | $33 | +106.2% | 404 | +96.1% | 0.03% | +314.3% |
Q4 2022 | $16 | – | 206 | +5050.0% | 0.01% | – |
Q3 2022 | $0 | – | 4 | -33.3% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 6 | -25.0% | 0.00% | -100.0% |
Q1 2022 | $1,000 | 0.0% | 8 | -20.0% | 0.00% | 0.0% |
Q4 2021 | $1,000 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |